Characterization of matrix metalloproteinase-2 and -9, ADAM-10 and N-cadherin expression in human glioblastoma multiforme

Cell and Tissue Research

Volumn 362, Issue 1, 2015, Pages 45-60

  Musumeci, Giuseppe ^a   Magro, Gaetano ^b   Cardile, Venera ^a   Coco, Marinella ^a   Marzagalli, Rubina ^a   Castrogiovanni, Paola ^a   Imbesi, Rosa ^a   Graziano, Adriana Carol Eleonora ^a   Barone, Fabio ^c   Di Rosa, Michelino ^a   Castorina, Sergio ^a,d   Castorina, Alessandro ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c CANNIZZARO HOSPITAL   (Italy)

^d Unit of Neurosurgery   (Italy)

Author keywords

ADAM 10; Glial tumors; Glioblastoma multiforme; Matrix metalloproteinase; N cadherin

Indexed keywords

ADAM10 ENDOPEPTIDASE; BETA TUBULIN; GELATINASE A; GELATINASE B; INTERLEUKIN 6; JANUS KINASE 2; MESSENGER RNA; NERVE CELL ADHESION MOLECULE; STAT3 PROTEIN; VASCULOTROPIN; ADAM PROTEIN; ADAM10 PROTEIN, HUMAN; CADHERIN; CDH2 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; MMP2 PROTEIN, HUMAN; MMP9 PROTEIN, HUMAN; SECRETASE; TUMOR MARKER;

ADAM 10 GENE; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CARCINOGENESIS; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; EPILEPSY; GENE; GENE EXPRESSION REGULATION; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IL 6 GENE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INTRACELLULAR SIGNALING; METASTASIS POTENTIAL; MMP 2 GENE; MMP 9 GENE; N CADHERIN GENE; NEUROPATHOLOGY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; REAL TIME POLYMERASE CHAIN REACTION; TRANSCRIPTION REGULATION; TUMOR INVASION; UPREGULATION; VEGF GENE; WESTERN BLOTTING; BIOSYNTHESIS; BRAIN TUMOR; CASE CONTROL STUDY; ENZYMOLOGY; GENETICS; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ADAM PROTEINS; AMYLOID PRECURSOR PROTEIN SECRETASES; ANTIGENS, CD; BIOMARKERS, TUMOR; BRAIN NEOPLASMS; CADHERINS; CASE-CONTROL STUDIES; CELL LINE, TUMOR; GLIOBLASTOMA; HUMANS; IMMUNOHISTOCHEMISTRY; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MEMBRANE PROTEINS; RNA, MESSENGER;

EID: 84941875616     PISSN: 0302766X     EISSN: 14320878     Source Type: Journal    
DOI: 10.1007/s00441-015-2197-5     Document Type: Article

References (57)

1. Asano K, Kubo O, Tajika Y, Takakura K, Suzuki S (2000) Expression of cadherin and CSF dissemination in malignant astrocytic tumors. Neurosurg Rev 23:39–44
2. Asano K, Duntsch CD, Zhou Q, Weimar JD, Bordelon D, Robertson JH, Pourmotabbed T (2004) Correlation of N-cadherin expression in high grade gliomas with tissue invasion. J Neurooncol 70:3–15
3. Castorina A, Leggio GM, Giunta S, Magro G, Scapagnini G, Drago F, D’Agata V (2011) Neurofibromin and amyloid precursor protein expression in dopamine D3 receptor knock-out mice brains. Neurochem Res 36:426–434
4. Castorina A, Giunta S, Scuderi S, D’Agata V (2012) Involvement of PACAP/ADNP signaling in the resistance to cell death in malignant peripheral nerve sheath tumor (MPNST) cells. J Mol Neurosci 48:674–683
5. Castorina A, D’Amico AG, Scuderi S, Leggio GM, Drago F, D'Agata V (2013) Dopamine D3 receptor deletion increases tissue plasminogen activator (tPA) activity in prefrontal cortex and hippocampus. Neuroscience 250:546–556
6. Castorina A, Scuderi S, D’Amico AG, Drago F, D’Agata V (2014) PACAP and VIP increase the expression of myelin-related proteins in rat schwannoma cells: involvement of PAC1/VPAC2 receptor-mediated activation of PI3K/Akt signaling pathways. Exp Cell Res 322:108–121
7. Castorina A, Waschek JA, Marzagalli R, Cardile V, Drago F (2015) PACAP interacts with PAC1 receptors to induce tissue plasminogen activator (tPA) expression and activity in Schwann cell-like cultures. PLoS ONE 10:e0117799
8. Cavallaro U (2004) N-cadherin as an invasion promoter: a novel target for antitumor therapy? Curr Opin Investig Drugs 5:1274–1278
9. Choe G, Park JK, Jouben-Steele L, Kremen TJ, Liau LM, Vinters HV, Cloughesy TF, Mischel PS (2002) Active matrix metalloproteinase 9 expression is associated with primary glioblastoma subtype. Clin Cancer Res 8:2894–2901
10. Drappatz J, Norden AD, Wen PY (2009) Therapeutic strategies for inhibiting invasion in glioblastoma. Expert Rev Neurother 9:519–534
11. Edwards LA, Woo J, Huxham LA, Verreault M, Dragowska WH, Chiu G, Rajput A, Kyle AH, Kalra J, Yapp D, Yan H, Minchinton AI, Huntsman D, Daynard T, Waterhouse DN, Thiessen B, Dedhar S, Bally MB (2008) Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of integrin-linked kinase (ILK). Mol Cancer Ther 7:59–70
12. Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2:161–174
13. Folgueras AR, Pendás AM, Sánchez LM, López-Otín C (2004) Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 48:411–424
14. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V (1997) Induction of cell migration by matrix metalloproteinase-2 cleavage of laminin-5. Science 277:225–228
15. Giunta S, Andriolo V, Castorina A (2014) Dual blockade of the A1 and A2A adenosine receptor prevents amyloid beta toxicity in neuroblastoma cells exposed to aluminum chloride. Int J Biochem Cell Biol 54:122–136
16. Goswami S, Gupta A, Sharma SK (1998) Interleukin-6-mediated autocrine growth promotion in human glioblastoma multiforme cell line U87MG. J Neurochem 71:1837–1845
17. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA (2000) Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol 148:779–790
18. Huang S (2007) Regulation of metastases by signal transducer and activator of transcription 3 signaling pathway: clinical implications. Clin Cancer Res 13:1362–1366
19. Huang D, Du X, Yuan R, Chen L, Liu T, Wen C, Huang M, Li M, Hao L, Shao J (2014) Rock2 promotes the invasion and metastasis of hepatocellular carcinoma by modifying MMP2 ubiquitination and degradation. Biochem Biophys Res Commun 453:49–56
20. Huovila AP, Turner AJ, Pelto-Huikko M, Kärkkäinen I, Ortiz RM (2005) Shedding light on ADAM metalloproteinases. Trends Biochem Sci 30:413–422
21. Iwamaru A, Szymanski S, Iwado E, Aoki H, Yokoyama T, Fokt I, Hess K, Conrad C, Madden T, Sawaya R, Kondo S, Priebe W, Kondo Y (2007) A novel inhibitor of the STAT3 pathway induces apoptosis in malignant glioma cells both in vitro and in vivo. Oncogene 26:2435–2444
22. Jiang C, Pecha J, Hoshino I, Ankrapp D, Xiao H (2007) TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin. Cancer Res 67:3574–3582
23. Kim JE, Patel M, Ruzevick J, Jackson CM, Lim M (2014) STAT3 activation in glioblastoma: biochemical and therapeutic implications. Cancers (Basel) 6:376–395
24. Kohutek ZA, diPierro CG, Redpath GT, Hussaini IM (2009) ADAM-10-mediated N-cadherin cleavage is protein kinase C-alpha dependent and promotes glioblastoma cell migration. J Neurosci 29:4605–4615
25. Lama G, Mangiola A, Anile C, Sabatino G, De Bonis P, Lauriola L, Giannitelli C, La Torre G, Jhanwar-Uniyal M, Sica G, Maira G (2007) Activated ERK1/2 expression in glioblastoma multiforme and in peritumor tissue. Int J Oncol 30:1333–1342
26. Liu L, Wu J, Ying Z, Chen B, Han A, Liang Y, Song L, Yuan J, Li J, Li M (2010a) Astrocyte elevated gene-1 upregulates matrix metalloproteinase-9 and induces human glioma invasion. Cancer Res 70:3750–3759
27. Liu Q, Li G, Li R, Shen J, He Q, Deng L, Zhang C, Zhang J (2010b) IL-6 promotion of glioblastoma cell invasion and angiogenesis in U251 and T98G cell lines. J Neurooncol 100:165–176
28. Loreto C, Leonardi R, Musumeci G, Pannone G, Castorina S (2013) An ex vivo study on immunohistochemical localization of MMP-7 and MMP-9 in temporomandibular joint discs with internal derangement. Eur J Histochem 57:e12
29. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97–109
30. Mangiola A, Saulnier N, De Bonis P, Orteschi D, Sica G, Lama G, Pettorini BL, Sabatino G, Zollino M, Lauriola L, Colabianchi A, Proietti G, Kovacs G, Maira G, Anile C (2013) Gene expression profile of glioblastoma peritumoral tissue: an ex vivo study. PLoS ONE 8:e57145
31. Martinez G, Musumeci G, Loreto C, Carnazza ML (2007) Immunohistochemical changes in vulnerable rat brain regions after reversible global brain ischaemia. J Mol Histol 38:295–302
32. Mayes DA, Hu Y, Teng Y, Siegel E, Wu X, Panda K, Tan F, Yung WK, Zhou YH (2006) PAX6 suppresses the invasiveness of glioblastoma cells and the expression of the matrix metalloproteinase-2 gene. Cancer Res 66:9809–9817
33. Munaut C, Noël A, Hougrand O, Foidart JM, Boniver J, Deprez M (2003) Vascular endothelial growth factor expression correlates with matrix metalloproteinases MT1-MMP, MMP-2 and MMP-9 in human glioblastomas. Int J Cancer 106:848–855
34. Musumeci G, Castrogiovanni P, Loreto C, Castorina S, Pichler K, Weinberg AM (2013a) Post-traumatic caspase-3 expression in the adjacent areas of growth plate injury site: a morphological study. Int J Mol Sci 14:15767–15784
35. Musumeci G, Trovato FM, Pichler K, Weinberg AM, Loreto C, Castrogiovanni P (2013b) Extra-virgin olive oil diet and mild physical activity prevent cartilage degeneration in an osteoarthritis model. An “in vivo” and “in vitro” study on lubricin expression. J Nutr Biochem 24:2064–2075
36. Nagase H, Visse R, Murphy G (2006) Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 69:562–573
37. Nowacki P, Kojder I (2001) Peritumoral angiogenesis around primary and metastatic brain neoplasms. Morphometric analysis. Folia Neuropathol 39:95–102
38. Omuro A, DeAngelis LM (2013) Glioblastoma and other malignant gliomas: a clinical review. JAMA 310:1842–1850
39. Payne LS, Huang PH (2013) The pathobiology of collagens in glioma. Mol Cancer Res 11:1129–1140
40. Péglion F, Etienne-Manneville S (2012) N-cadherin expression level as a critical indicator of invasion in non-epithelial tumors. Cell Adh Migr 6:327–332
41. Puzzo D, Loreto C, Giunta S, Musumeci G, Frasca G, Podda MV, Arancio O, Palmeri A (2014) Effect of phosphodiesterase-5 inhibition on apoptosis and beta amyloid load in aged mice. Neurobiol Aging 35:520–531
42. Qi J, Chen N, Wang J, Siu CH (2005) Transendothelial migration of melanoma cells involves N-cadherin-mediated adhesion and activation of the beta-catenin signaling pathway. Mol Biol Cell 16:4386–4397
43. Rahme GJ, Israel MA (2014) Id4 suppresses MMP2-mediated invasion of glioblastoma-derived cells by direct inactivation of Twist1 function. Oncogene 34:53–62
44. Rich JN, Hans C, Jones B, Iversen ES, McLendon RE, Rasheed BK, Dobra A, Dressman HK, Bigner DD, Nevins JR, West M (2005) Gene expression profiling and genetic markers in glioblastoma survival. Cancer Res 65:4051–4058
45. Senft C, Priester M, Polacin M, Schröder K, Seifert V, Kögel D, Weissenberger J (2011) Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells. J Neurooncol 101:393–403
46. Shinoura N, Paradies NE, Warnick RE, Chen H, Larson JJ, Tew JJ, Simon M, Lynch RA, Kanai Y, Hirohashi S et al (1995) Expression of N-cadherin and alpha-catenin in astrocytomas and glioblastomas. Br J Cancer 72:627–633
47. Sica G, Lama G, Anile C, Geloso MC, La Torre G, De Bonis P, Maira G, Lauriola L, Jhanwar-Uniyal M, Mangiola A (2011) Assessment of angiogenesis by CD105 and nestin expression in peritumor tissue of glioblastoma. Int J Oncol 38:41–49
48. Signore M, Pelacchi F, di Martino S, Runci D, Biffoni M, Giannetti S, Morgante L, De Majo M, Petricoin EF, Stancato L, Larocca LM, De Maria R, Pallini R, Ricci-Vitiani L (2014) Combined PDK1 and CHK1 inhibition is required to kill glioblastoma stem-like cells in vitro and in vivo. Cell Death Dis 5:e1223
49. Smith JS, Tachibana I, Passe SM, Huntley BK, Borell TJ, Iturria N, O’Fallon JR, Schaefer PL, Scheithauer BW, James CD, Buckner JC, Jenkins RB (2001) PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. J Natl Cancer Inst 93:1246–1256
50. Stevenson CB, Ehtesham M, McMillan KM, Valadez JG, Edgeworth ML, Price RR, Abel TW, Mapara KY, Thompson RC (2008) CXCR4 expression is elevated in glioblastoma multiforme and correlates with an increase in intensity and extent of peritumoral T2-weighted magnetic resonance imaging signal abnormalities. Neurosurgery 63:560–569, discussion 569–570
51. Stupp R, Hegi ME, van den Bent MJ, Mason WP, Weller M, Mirimanoff RO, Cairncross JG. (2006) Changing paradigms–an update on the multidisciplinary management of malignant glioma. Oncologist 11:165–180
52. Sturm D, Bender S, Jones DT, Lichter P, Grill J, Becher O, Hawkins C, Majewski J, Jones C, Costello JF, Iavarone A, Aldape K, Brennan CW, Jabado N, Pfister SM (2014) Paediatric and adult glioblastoma: multiform (epi)genomic culprits emerge. Nat Rev Cancer 14:92–107
53. Surgucheva I, Chidambaram K, Willoughby DA, Surguchov A (2010) Matrix metalloproteinase 9 expression: new regulatory elements. J Ocul Biol Dis Inf 3:41–52
54. Urbańska K, Lynn RC, Stashwick C, Thakur A, Lum LG, Powell DJ Jr (2014) Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells. J Transl Med 12:347
55. Utsuki S, Sato Y, Oka H, Tsuchiya B, Suzuki S, Fujii K (2002) Relationship between the expression of E-, N-cadherins and beta-catenin and tumor grade in astrocytomas. J Neurooncol 57:187–192
56. Velpula KK, Rehman AA, Chelluboina B, Dasari VR, Gondi CS, Rao JS, Veeravalli KK (2012) Glioma stem cell invasion through regulation of the interconnected ERK, integrin α6 and N-cadherin signaling pathway. Cell Signal 24:2076–2084
57. Watanabe K, Tachibana O, Sata K, Yonekawa Y, Kleihues P, Ohgaki H (1996) Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas. Brain Pathol 6:217–223, discussion 23–24